-
Symbol
-
DNTH on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
2,416,667 shares
-
Security Ownership %
-
6.1%
Shares, Excluding Options vs Price
Octagon Capital Advisors LP ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH)
14 Nov 2025 - Octagon Capital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,416,667 shares of Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH).
This represents 6.1% ownership of the company.
In their previous filing dated 05 Feb 2025, Octagon Capital Advisors LP had reported owning 2,110,167 shares, indicating an increase of +15%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.